Surbhi Sarna

Surbhi Sarna founded nVision Medical in 2011, whereas CEO, led the company to develop a first-of-its-kind microcatheter for the detection of ovarian cancer. Following an acquisition by Boston Scientific in 2018, Surbhi led the commercial effort of the nVision technology at Boston Scientific until 2020. Prior to the founding of nVision, Ms. Sarna held roles in healthcare engineering at BioCardia and Abbott Vascular.

Ms. Sarna is currently a Group Partner at Y Combinator and is a board member of Penumbra, Inc. She is also on the board of trustees at Astia, an organization committed to leveling the playing field by providing access to capital and networks to women entrepreneurs. She received a Bachelor of Science in Molecular and Cell Biology from the University of California, Berkeley.